1. Can you give us an outline of your role at Akari? Scientific input and oversight to all areas of Akari’s work including strategic direction, regulatory …
[Read more...] about Q&A with Miles Nunn, Chief Scientific Officer
AN INNOVATIVE TARGETED ONCOLOGY COMPANY BUILT ON NEXT GENERATION ANTIBODY-DRUG CONJUGATES (ADC) AND A NOVEL DISCOVERY ENGINE
Footer
Follow Us
